Navigation Links
Today's Research: Inovio Pharma, Sequenom, Peregrine Pharma, Onyx Pharma, and Optimer Pharma
Date:6/20/2013

LONDON, June 20, 2013 /PRNewswire/ --

The U.S. Supreme Court's decision last week on human gene patents is likely to have a major impact on the biotechnology industry, especially on smaller companies. The Supreme Court last week ruled that a naturally occurring DNA segment is a product of nature, and not patent-eligible just because it has been isolated. On Wednesday, June 19, 2013, shares in biotechnology companies ended mostly lower, tracking losses in the broader market, which fell sharply after market participants digested comments from Federal Reserve Chairman Ben Bernanke. The major movers in the sector included Inovio Pharmaceuticals Inc. (AMEX: INO), Sequenom Inc. (NASDAQ: SQNM), Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM), Onyx Pharmaceuticals Inc. (NASDAQ: ONXX), and Optimer Pharmaceuticals Inc. (NASDAQ: OPTR). AAAResearchReports.com have completed their technical analysis on INO, SQNM, PPHM, ONXX, and OPTR and these free reports are accessible by registering at

http://www.aaaresearchreports.com/register/  

Shares in Inovio Pharmaceuticals Inc. moved lower on Wednesday, reversing some of their gains from earlier in the week. The company's shares traded between $0.66 and $0.70 before finishing the day 0.57% lower at $0.69. A total of 758,372 shares were traded which is below the daily average volume of 1.36 million. Shares of INO are now up more than 3.70% for this week. Sign up for free technical research on INO at:


SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medical Devices Research: Country Reports on Market Profile, Competitive Environment and more at RnRMarketResearch.com
2. New Research: Nationwide Report Shows Prescribed Drugs Not Detected in More Than One-Third of Pain Patient Samples
3. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
4. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
5. Inovio Pharmaceuticals to Present at SPI 2012
6. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
7. Inovio Pharmaceuticals to Present at JMP Investor Conference
8. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
9. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
10. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Holdings, Inc. (NYSE and SIX: ZMH) is celebrating a key milestone in ... Knee System. ,   ... introduced the NexGen knee system, with its innovative design and ... of the NexGen knee have taken place worldwide. ... the importance of design innovation and component quality for surgeons and patients ...
(Date:3/27/2015)... 27, 2015 CHINA ... Senior Care, Rehabilitation Medicine and Healthcare, second to none ... will be held at Shanghai New International Expo Center ... 2015,  Implementation Suggestions on Encouraging Private Capital to Participate ... was jointly issued by the Ministry of Civil Affairs of ...
(Date:3/27/2015)... According to a new market ... Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices ... WPW) - Global Forecasts to 2019 ", published by MarketsandMarkets, ... ~$4.73 Billion by 2019 with a CAGR of around ... Browse   90   ma rket ...
Breaking Medicine Technology:Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4
... Alcon, Inc. (NYSE: ACL ) and its ... today that Alcon has begun treating patients in a Phase ... for viral conjunctivitis, a type of "pink eye". Conjunctivitis ... and children, leading to more than four million doctor and ...
... and BRISTOL, Tenn., July 2 Acura Pharmaceuticals, Inc. (Nasdaq: ... KG ) announced today that the U.S. Food and ... the New Drug Application (NDA) for Acurox (oxycodone HC1, USP ... for the relief of moderate-to-severe pain. , ...
Cached Medicine Technology:Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis 2Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis 3Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis 4Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 3
(Date:3/29/2015)... 29, 2015 At this initial ... provides basic health information around medical conditions that ... these challenges as well as helping them find ... six medical conditions using evidenced based information in ... in conversations around them., , ...
(Date:3/29/2015)... North American Seminars receives Texas Board Physical Therapy ... . , Utilizing Pilates to Enhance Rehab ... # 56399TX      , The Interactive Shoulder Algorithm ... 10.5 hours - Texas Board of Physical Therapy      ... the SI Joint - 10 hours - Texas Board ...
(Date:3/28/2015)... March 28, 2015 Coffee could not only ... protect you from gum disease, researchers have found. , They ... disease. , Coffee contains antioxidants. Antioxidants fight gum disease. Does ... researchers at Boston Univ. Henry M. Goldman School of Dental ... August 2014 issue of the Journal of Periodontology. , “This ...
(Date:3/28/2015)... March 28, 2015 Take a bite ... kicks into action. Acids tumble into the stomach, ready ... faulty valve-like structure lets these acids run amok, triggering ... extremely common symptom. More than 60 million Americans have ... examine where heartburn starts, and how it can be ...
(Date:3/28/2015)... California-based leading wig brand UniWigs has prepared a mysterious ... the Easter Holidays from today until April 6th. There ... Day. , As the winter fades and spring approaches, ... with religious origins to countries in Europe and the ... best wig provider, UniWigs, would like to offer a ...
Breaking Medicine News(10 mins):Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 3Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2
... MORRISVILLE, Pa., Feb. 13 As the FDA ... risk evaluation and mitigation plans for extended release ... chronic pain have already discovered a resource that ... treatments. Emerging Solutions in Pain ( ...
... do more to promote awareness, study says , , FRIDAY, Feb. ... by name or role -- the doctors assigned to their ... , "The majority of hospitalized patients we looked at were ... said study author Dr. Vineet Arora, associate program director at ...
... national survey conducted by the Harvard Opinion Research Program at ... majority (93%) of Americans have heard or read about the ... aware of the recall, about six in ten (61%) say ... risk of getting sick from contaminated peanut products. Specifically, about ...
... YORK, Feb. 13 In a bid to help ... online auction of the Ysio Digital Radiology System, donated ... at $99,999 and jumped to a quarter million dollars ... Siemens (NYSE: SI ) at: , ...
... are under way , , FRIDAY, Feb. 13 (HealthDay ... Chinese medicine may be able to control allergic reactions ... City,s Mount Sinai School of Medicine report. , Food ... allergies among children have increased 18 percent since 1997, ...
... Corporation (Nasdaq: DYNT ) today announced results for ... 2008. Operating results showed significant improvement over the three and ... quarter ended December 31, 2008, improved to $89,917, compared to ... the prior fiscal year. Net income for the quarter ended ...
Cached Medicine News:Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 2Health News:Opioid Safety and Efficacy Web Resource for Clinicians Supports Education and Practice Needs 3Health News:Many Hospital Patients Can't ID Their Doctors 2Health News:Many Hospital Patients Can't ID Their Doctors 3Health News:Following peanut product recall, six in ten Americans taking steps to reduce risk of sickness 2Health News:Following peanut product recall, six in ten Americans taking steps to reduce risk of sickness 3Health News:Herbal Remedy Could Halt Peanut Allergy 2Health News:Herbal Remedy Could Halt Peanut Allergy 3Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 2Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 3Health News:Dynatronics Reports Profitable Second Quarter - Signaling Significant Improvement Over Prior Year Results 4
The ADx system uses fluorescence polarization immunoassay technology for the detection of abused drugs and toxicology assays....
Innotrac Aio! immunoanalyzers are specially designed to exploit the benefits of Innotrac Diagnostics' exclusive dry chemistry and non-enhancement time-resolved fluorometry....
... The Access immunoassay system ... access benchtop analyzer that ... assays, with panels that ... thyroid, infectious disease, blood ...
...
Medicine Products: